Article Information
History
- September 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Hye Kyung Lee1,*,†,
- Ludwig Knabl2,*,†,
- Ludwig Knabl Sr.3,
- Sebastian Kapferer4,
- Birgit Pateter5,
- Mary Walter6,
- Priscilla A. Furth7,† and
- Lothar Hennighausen1,†
- 1National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, MD 20892, USA
- 2TyrolPath, Zams, Austria
- 3Krankenhaus St. Vinzenz, Zams, Austria
- 4Division of Internal Medicine, Krankenhaus Kufstein, Kufstein, Austria
- 5Dr. Pateter’s surgery, Fliess, Austria
- 6Clinical Core, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, MD 20892, USA
- 7Departments of Oncology & Medicine, Georgetown University, Washington, DC, USA
- ↵†Corresponding authors: HKL: hyekyung.lee{at}nih.gov; LK: Ludwig.knabl{at}tyrolpath.at; PAF: paf3{at}georgetown.edu; LH: lotharh{at}nih.gov
↵* Equal contribution
Posted September 12, 2021.
Robust immune response to the BNT162b mRNA vaccine in an elderly population vaccinated 15 months after recovery from COVID-19
